Comparison between Nephro Care IPO and Visaman Global Sales IPO.
IPO Details
Nephro Care IPO is a SME Fixed Price IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Nephro Care IPO is up to ₹39.18 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹15.22 Cr. The final issue price of Nephro Care IPO is ₹90.00 per share and of Visaman Global Sales IPO is ₹43.00 per share.
IPO Timetable
Nephro Care IPO opens on Jun 28, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Nephro Care IPO and Visaman Global Sales IPO is Jul 02, 2024, and Jun 26, 2024, respectively.
| | Nephro Care IPO | Visaman Global Sales IPO |
|---|
| Anchor Bid Date | Jun 27, 2024 | |
| Issue Open | Jun 28, 2024 | Jun 24, 2024 |
| Issue Close | Jul 02, 2024 | Jun 26, 2024 |
| Basis Of Allotment (Tentative) | Jul 03, 2024 | Jun 27, 2024 |
| Initiation of Refunds (Tentative) | Jul 04, 2024 | Jun 28, 2024 |
| Credit of Share (Tentative) | Jul 04, 2024 | Jun 28, 2024 |
| Listing date (Tentative) | Jul 05, 2024 | Jul 01, 2024 |
| Anchor Lockin End date 1 | Aug 02, 2024 | |
| Anchor Lockin End date 2 | Oct 01, 2024 | |
Financials & KPIs
Nephro Care IPO P/E ratio is 55.15, as compared to Visaman Global Sales IPO P/E ratio of 38.25.
Shares Offered
In the Nephro Care IPO Retail Individual Investors (RII) are offered 14,44,800 shares while in Visaman Global Sales IPO retail investors are offered 14,44,800 shares. Qualified Institutional Buyers (QIB) are offered 8,25,600 shares in Nephro Care IPO and 0 shares in Visaman Global Sales IPO.
| | Nephro Care IPO | Visaman Global Sales IPO |
|---|
| Anchor Investor Reservation | 12,38,400 shares | 0 shares |
| Market Maker Reservation | 2,30,400 shares | 1,92,000 shares |
| QIB | 8,25,600 shares | 0 shares |
| NII | 6,19,200 shares | 17,70,000 shares |
| RII | 14,44,800 shares | 17,70,000 shares |
| Employee | 2,25,600 shares | 0 shares |
| Others | | |
| Total | 43,53,600 shares | 35,40,000 shares |
Bids Received (Subscription)
Nephro Care IPO subscribed 715.78x in total, whereas Visaman Global Sales IPO subscribed 42.20x.
